Does long-term culture favor normal clonogenic cells from interferon-treated patients with chronic myelogenous leukemia?

We have tested whether peripheral blood mononuclear cells (PBMNCs) from interferon (IFN)-treated patients may lose residual BCR-ABL sequence-positive progenitor cells when long-term cultured for 35 days on allogeneic stromal cells. IFN-treated patients have low white blood cell counts and a fair num...

Full description

Saved in:
Bibliographic Details
Main Authors: Pasternak, Günter (Author) , Schultheis, Beate (Author) , Heissig, Beate (Author) , Hörner, Susanne (Author) , Sick, Christian (Author) , Hehlmann, Rüdiger (Author)
Format: Article (Journal)
Language:English
Published: 15 June 1999
In: Leukemia
Year: 1999, Volume: 13, Pages: S55-S64
ISSN:1476-5551
DOI:10.1038/sj.leu.2401288
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.leu.2401288
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/2401288
Get full text
Author Notes:G. Pasternak, B. Schultheis, B. Heissig, S. Hörner, C. Sick and R. Hehlmann
Description
Summary:We have tested whether peripheral blood mononuclear cells (PBMNCs) from interferon (IFN)-treated patients may lose residual BCR-ABL sequence-positive progenitor cells when long-term cultured for 35 days on allogeneic stromal cells. IFN-treated patients have low white blood cell counts and a fair number of BCR-ABL-negative colony-forming cells in the peripheral blood. Particularly, IFN responders show increased numbers of normal hematopoietic cells. We have quantitatively analyzed progenitor cells in PBMNCs of IFN-treated patients by combining the clonogenic assay in semisolid medium with interphase fluorescent in situ hybridization (FISH). Thus, the identification is possible of the BCR-ABL status of colony-forming progenitor cells. In IFN-treated patients, the number of BCR-ABL-positive CFCs is considerably decreased and BCR-ABL-negative CFCs appear in the peripheral blood. We could show that after LTC for 35 days of the same PBMNCs on irradiated allogeneic normal stromal cells residual BCR-ABL sequence-positive CFCs were still present. In some cases the relative number of BCR-ABL sequence-positive CFCs was found to be increased after LTC. A minor proportion of blood samples from IFN-treated patients did not give rise to CFCs after LTC on allogeneic stromal cells (three of 10 patients). Inter- and intraindividual variations can be found with regard to loss or gain of BCR-ABL sequence-positive colonies after LTC. We conclude that early CML progenitor cells persist in the peripheral blood of IFN-treated patients and that a certain proportion may survive long-term culture.
Item Description:Gesehen am 19.05.2022
Physical Description:Online Resource
ISSN:1476-5551
DOI:10.1038/sj.leu.2401288